Nina Ånensen

Vitenskapelige publikasjoner

Ånensen, Nina ; Hjelle, Sigrun Margrethe; Van, Belle Werner; Haaland, Ingvild; Silden, Elisabeth; Bourdon, Jean-Christophe; Hovland, Randi; Tasken, Kjetil; Knappskog, Stian; Lønning, Per Eystein; Bruserud, Øystein; Gjertsen, Bjørn Tore (2012). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene. Vol. 31.
https://doi.org/10.1038/onc.2011.348

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer. Vol. 9.
https://doi.org/10.1186/1471-2407-9-77

Ånensen, Nina ; Øyan, Anne Margrete; Huseby, Sjur; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. Vol. 7.
https://doi.org/10.1586/14737140.7.5.741

Gjertsen, Bjørn Tore; Bredholt, Therese; Ånensen, Nina ; Vintermyr, Olav (2007). Bcl-2 antisense in the treatment of human malignancies: A delusion in targeted therapy. Current Pharmaceutical Biotechnology. Vol. 8.
https://doi.org/10.2174/138920107783018381

Irish, Jonathan C.; Ånensen, Nina ; Hovland, Randi; Skavland, Jørn; Børresen-Dale, Anne-Lise; Bruserud, Øystein; Nolan, Gary P; Gjertsen, Bjørn Tore (2007). Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood. Vol. 109.
https://doi.org/10.1182/blood-2006-02-004234

Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta; Ånensen, Nina ; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein (2007). Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. 16 s. European Journal of Haematology. Vol. 79.
https://doi.org/10.1111/j.1600-0609.2007.00899.x

Bruserud, Øystein; Stapnes, Camilla I; Tronstad, Karl Johan; Ryningen, Anita; Ånensen, Nina ; Gjertsen, Bjørn Tore (2006). Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert opinion on therapeutic targets. Vol. 10.
https://doi.org/10.1517/14728222.10.1.51

Ånensen, Nina ; Haaland, Ingvild; D Santos, Clive; Belle, Werner Van; Gjertsen, Bjørn Tore (2006). Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Current Pharmaceutical Biotechnology. Vol. 7.
https://doi.org/10.2174/138920106777549731

Ånensen, Nina ; Øyan, Anne Margrete; Bourdon, Jean-Christophe; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. 8 s. Clinical Cancer Research. Vol. 12.
https://doi.org/10.1158/1078-0432.CCR-05-1970

Van Belle, Werner; Sjøholt, Gry; Ånensen, Nina ; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore (2006). Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment. Electrophoresis. Vol. 27.
https://doi.org/10.1002/elps.200500925

Forskningsrapporter

Ånensen, Nina ; Gjertsen, Bjørn Tore (2006). p53 protein biosignatures in acute myeloid leukemia. ISBN: 82-308-0127-4. Universitetet i Bergen.
http://www.uib.no/info/dr_grad/2006/Aanensen_Nina.

Formidling

Ånensen, Nina ; Skavland, Jørn; Stapnes, Camilla I; Ryningen, Anita; Børresen-Dale, Anne-Lise; Gjertsen, Bjørn Tore; Bruserud, Øystein (2006). Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report. Leukemia. Vol. 20.
https://doi.org/10.1038/sj.leu.2404117

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. 7th Bergen Conference on Cancer Research. LOCUS for Cancer Research, University of Bergen.

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. 11th World Congress on Advances in Oncology. Medical School, University of Crete.

Sandal, Tone; Krakstad, Camilla; Ånensen, Nina ; Gjertsen, Bjørn Tore; Døskeland, Stein Ove; Hedin, Lars Flemming (2003). Myeloid leukemia cell differentiation by bcl-2 and camp involves induction of ccaat/enhancer binding protein ? (c/ebp?), nuclear accumulation of c/ebp?, and direct interaction between bcl-2 and c/ebp?. The Fourth International Conference on Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Development.